Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. The company exports its products through a network of distributors and agents in approximately 30 countries. It serves patients, surgeons, and healthcare facilities. Amplitude Surgical SA was founded in 1997 and is headquartered in Valence, France. As of July 29, 2025, Amplitude Surgical SA operates as a subsidiary of Zydus Lifesciences Limited.
Frequently asked questions
What sector does Amplitude Surgical SAS (AMPLI) operate in?
Amplitude Surgical SAS belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Amplitude Surgical SAS (AMPLI) current stock price?
As of the latest data, Amplitude Surgical SAS stock price is €6.25, with a previous close of €6.25.
What is Amplitude Surgical SAS (AMPLI) current market capitalization?
Amplitude Surgical SAS market cap is approximately 299.85 million.
What is Amplitude Surgical SAS (AMPLI) Earnings Per Share (EPS)?
The trailing EPS is €0.02.
What is Amplitude Surgical SAS (AMPLI) Price-to-Earnings (P/E) ratio?
Amplitude Surgical SAS current P/E ratio is 312.5.
Does Amplitude Surgical SAS (AMPLI) pay dividends?
No. Amplitude Surgical SAS does not pay a dividend.
What is Amplitude Surgical SAS (AMPLI) beta (volatility) score?
Amplitude Surgical SAS has a beta of 0.123, indicating lower volatility than the overall market.
